Immuneering Corporation (IMRX)

NASDAQ: IMRX · Real-Time Price · USD

4.410

0.00 (0.00%)

At close: Jun 18, 2026, 4:00 PM EDT

4.390

-0.020 (-0.45%)

After-hours: Jun 18, 2026, 7:14 PM EDT

Immuneering Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	47.32	128.65	36.14	59.41	72.64	74.89
Short-Term Investments	109.37	44.19	-	26.26	32.89	74.31
Cash & Short-Term Investments	156.69	172.83	36.14	85.67	105.53	149.2
Cash Growth	336.89%	378.16%	-57.81%	-18.82%	-29.27%	302.26%
Accounts Receivable	-	-	-	-	0.01	0.25
Other Current Assets	4.72	3.41	3.44	3.42	3.21	2.89
Total Current Assets	161.41	176.25	39.59	89.08	108.75	152.33
Net Property, Plant & Equipment	4.17	4.26	4.79	5.4	5.78	6.13
Other Intangible Assets	0.31	0.32	0.35	0.38	0.41	0.44
Goodwill	6.69	6.69	6.69	6.69	6.69	6.7
Long-Term Investments	41.95	44.18	-	-	-	1
Other Long-Term Assets	0.28	0.28	1.3	1.03	0.74	0.1
Total Assets	214.81	231.99	52.71	102.59	122.37	166.71
Accounts Payable	1.45	1.54	1.96	2.11	3.15	1.39
Accrued Expenses	3.06	7.84	4.97	5.17	4.5	3.97
Current Portion of Leases	0.41	0.4	0.34	0.3	0.38	0.27
Other Current Liabilities	0.04	0.29	0.23	0.26	0.02	-
Total Current Liabilities	4.97	10.07	7.5	7.85	8.05	5.63
Long-Term Leases	3.32	3.43	3.82	4.16	4.46	5.09
Total Long-Term Liabilities	3.32	3.43	3.82	4.16	4.46	5.09
Total Liabilities	8.29	13.5	11.33	12.01	12.52	10.72
Common Stock	0.06	0.06	0.03	0.03	0.03	0.03
Additional Paid-in Capital	500.48	498.66	265.65	253.81	219.64	215.28
Accumulated Other Comprehensive Income	-0.24	0.08	-	-0	-0.03	-0.05
Retained Earnings	-293.78	-280.32	-224.3	-163.26	-109.79	-59.27
Total Common Shareholders' Equity	206.52	218.48	41.39	90.58	109.85	155.98
Shareholders' Equity	206.52	218.48	41.39	90.58	109.85	155.98
Total Liabilities & Equity	214.81	231.99	52.71	102.59	122.37	166.71
Total Debt	3.73	3.82	4.16	4.46	4.84	5.36
Net Cash (Debt)	152.96	169.01	31.98	81.2	100.68	143.83
Net Cash Growth	-9.49%	428.45%	-60.61%	-19.35%	-30.00%	294.40%
Net Cash Per Share	2.99	3.84	1.07	2.86	3.82	10.57
Book Value	206.52	218.48	41.39	90.58	109.85	155.98
Book Value Per Share	4.03	4.96	1.38	3.19	4.16	11.46
Tangible Book Value	199.51	211.47	34.35	83.51	102.75	148.84
Tangible Book Value Per Share	3.89	4.80	1.15	2.94	3.89	10.93

SEC Filings: 10-K · 10-Q